Press release
Hunan Huateng Pharmaceutical to Exhibit Advanced PEG Derivatives and CDMO Solutions at CPHI China 2026
Huateng Pharma will welcome pharmaceutical professionals, biotech innovators, sourcing specialists, and manufacturing partners at Booth W3P16, where the company will showcase its latest developments in high-purity PEG derivatives and custom manufacturing capabilities for pharmaceutical and specialty chemical applications.
As demand continues to rise for reliable raw materials and scalable development solutions in biopharmaceutical manufacturing, Huateng Pharma offers integrated support spanning R&D, process development, scale-up, and commercial production.
At CPHI China 2026, visitors will have the opportunity to explore the company's GMP-grade PEG derivatives, available from gram quantities to 100 kg scale, supporting applications such as drug delivery, long-acting therapeutics, conjugation chemistry, biomaterials, and pharmaceutical formulation development.
The featured PEG product portfolio includes:
Polydispersed PEGs (M.W. 200-43,000 Da)
Monodispersed PEGs (Units: 1-48)
Multi-arm PEGs designed for advanced bioconjugation and material applications
In addition to PEG technologies, Huateng Pharma provides comprehensive CDMO services covering pharmaceutical intermediates, cosmetic ingredients, and specialty chemicals, helping customers accelerate development timelines while maintaining quality and manufacturing flexibility.
Representative CDMO products include:
Methacrylonitrile (CAS 126-98-7)
Diethyl chloromalonate (CAS 14064-10-9)
Tetrahydrocurcumin (CAS 36062-04-1)
4-Methylpyrazole (CAS 7554-65-6)
4-(Tert-butyl)-1,2-phenylene dibenzoate (CAS 1232839-88-1)
Piroctone olamine (CAS 68890-66-4)
Diethylamino hydroxybenzoyl hexyl benzoate (CAS 302776-68-7)
Methyl-3-(4-bromomethyl)cinnamate (CAS 946-99-6)
2-Methyl-5-bromobenzoic acid (CAS 79669-49-1)
CEO Dr. Deng will attend the exhibition and welcomes conversations with industry peers, researchers, and business partners regarding innovation in PEG chemistry, raw material development, and scalable manufacturing strategies.
"CPHI China is an important platform for knowledge exchange and industry collaboration," said Dr. Deng, CEO of Hunan Huateng Pharmaceutical Co., Ltd. "We look forward to meeting partners from across the pharmaceutical and biotech sectors to discuss technical challenges, manufacturing needs, and future opportunities."
Event Details
Event: CPHI China 2026
Date: June 16-18, 2026
Venue: Shanghai New International Expo Center (SNIEC), Shanghai, China
Booth: W3P16
Visitors are invited to meet the Huateng Pharma team to discuss PEG technologies, pharmaceutical intermediates, and custom CDMO solutions for research and commercial manufacturing.
Website: https://us.huatengsci.com
Email: sales@huatengusa.com
Zip code: 410205
Telephone: +86 731 89916275
Fax: + 86 731-82251112 EXT 818
Headoffice: Building E1, Lugu Corporation Plaza, High-Tech Industrial Development Zone, Changsha City, Hunan Province, P.R.China
Hunan Huateng Pharmaceutical Co., Ltd. is a world-leading supplier of PEG derivatives and a CDMO provider for APIs and intermediates, supporting projects from R&D lab supply to commercial production. The company provides comprehensive support for the biopharmaceutical industry through PEG technology and delivers tailor-made raw material solutions for the chemical and pharmaceutical sectors with advanced CDMO capabilities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hunan Huateng Pharmaceutical to Exhibit Advanced PEG Derivatives and CDMO Solutions at CPHI China 2026 here
News-ID: 4525413 • Views: …
More Releases from Hunan Huateng Pharmaceutical Co. Ltd.
Huateng Pharma Supplies Minoxidil Intermediate 2,4-Diamino-6-chloropyrimidine (C …
Minoxidil was first introduced by Upjohn Company of the United States, and was first used as an oral drug for the treatment of refractory hypertension in the 1970s. In later clinical applications, doctors observed hair regrowth and generalized excessive hair in balding patients, which led to the development of minoxidil preparations.
Minoxidil can increase local blood supply, stimulate the proliferation and differentiation of hair follicle epithelial cells, so as to promote…
Huateng Pharma Supplies Anti-diabetic API Intermediates With Huge Stock
Diabetes is a serious chronic disease characterized by elevated blood sugar concentrations associated with the effects of abnormal beta cell biology on insulin action. Diabetes occurs when the pancreas does not produce enough insulin or the body does not use the insulin it does produce efficiently.
The most common forms of diabetes are type 1 diabetes and type 2 diabetes. Type 1 diabetes is characterized by insufficient insulin production and…
Huateng Pharma Supplies Some Intermediates of CDK4/6 Inhibitors for Treatment of …
Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and also causes the greatest number of cancer-related deaths among women. In 2018, it is estimated that 627,000 women died from breast cancer - that is approximately 15% of all cancer deaths among women. While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally.
The majority…
ADC Drugs For HER2 Positive Breast Cancer
According to the latest data, breast cancer has overtaken lung cancer to become the most common cancer among women, and the death rate is the second highest among female tumors, seriously affecting the physical and mental health of women around the world. Patients with abnormal expression of human epidermal growth factor receptor (HER2) account for 15%-20% of all breast cancers, which is highly invasive and has poor prognosis.
Although more drug…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
